<DOC>
	<DOCNO>NCT00553319</DOCNO>
	<brief_summary>The propose protocol 3 group double-blind , placebo-controlled outpatient study safety efficacy Adderall-XR ( ER-MAS ) treatment comorbid ADHD cocaine dependence . Since medication independently show promise help ADHD cocaine abuse , propose may successful treatment comorbid ADHD cocaine abuse . We plan enroll 75 subject 14-week trial . The primary objective study determine efficacy ER-MAS promote cocaine abstinence improvement ADHD symptomology among cocaine-dependent patient comorbid ADHD .</brief_summary>
	<brief_title>Study Adderall-XR Treatment Adult Attention Deficit Hyperactivity Disorder Cocaine Dependence</brief_title>
	<detailed_description>Specific Aim 1 : To determine efficacy ER-MAS promote cocaine abstinence ADHD improvement among comorbid ADHD cocaine-dependent patient . Primary Hypothesis : benzoylecgonine positive urine screen decrease great least reduction 80mg &gt; 60mg &gt; PBO ( placebo ) . Hypothesis 2 : ADHD-Rating Scale decrease great least reduction 80mg &gt; 60mg &gt; PBO . Specific Aim 2 : To determine effect ER-MAS improve general functioning impulsivity among comorbid ADHD cocaine-dependent patient . Hypothesis 4 : There great improve CGI ( clinical global impression scale ) score participant receive d-AMPH ( d-amphetamine ) compare PBO . Hypothesis 5 : ER-MAS decrease impulsivity measure several self-report ( Barratts Impulsivity Scale ) behavioral measure ( Card Sort , IMT ( immediate memory task ) , DMT ( delayed memory task ) , BART ) compare PBO . This 14-week , three arm ( two medication dos versus PBO ) , prospective , parallel group , randomize PBO-controlled trial lead-in well medication run-up run week , provide clear data efficacy safety definitive Phase III trial , successful lead improve treatment A-ADHD/S-SUD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Adderall</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>1 . Men woman age 1860 meet DSMIV criterion current cocaine dependence adult ADHD ( DSMIVTR ) . 2 . Used cocaine least four day past month 3 . Must Body Mass Index ( BMI ) &gt; 18 kg/m2 4 . Alcohol Breathalyzer ( BraC ) consent &lt; 0.04 % 5 . Individuals must capable give informed consent capable comply study procedure . 6 . Women child bear age include study provide pregnant , base result blood pregnancy test drawn time screen . They must also agree use method contraception proven efficacy agree become pregnant study . To confirm , blood pregnancy test repeat monthly . Women provide full explanation potential danger pregnancy study medication . If woman become pregnant , study medication discontinue . 1 . Meets DSMIVTR criterion bipolar disorder , schizophrenia psychotic disorder transient psychosis due drug abuse . 2 . Individuals current Axis I psychiatric disorder define DSMIVTR support SCIDI/P investigator 's judgment unstable would disrupt study medication likely require pharmacotherapy study period . 3 . Individuals current major depressive disorder.However , individual currently stable psychotropic medication three month HAMD &lt; 14 may include . 4 . Individuals physiologically dependent drug ( exclude nicotine cannabis ) require medical intervention . 5 . Individuals current suicidal risk . 6 . Individuals coronary vascular disease indicate history suspect abnormal ECG , cardiac symptom , fainting , openheart surgery and/or arrhythmia , family history ventricular tachycardia/sudden death . 7 . Unstable physical disorder might make participation hazardous uncontrolled hypertension ( SBP &gt; 140 , DBP &gt; 90 , HR &gt; 100 sit quietly ) , acute hepatitis ( patient chronic mildly elevated transaminase &lt; 3x upper limit normal acceptable ) , uncontrolled diabetes . 8 . Individuals history seizures 9 . History allergic reaction candidate medication ( amphetamine and/or ERMAS ) . 10 . Women pregnant nursing . 11 . History failure respond previous adequate trial candidate medication cocaine dependence 12 . Individuals legally mandate ( e.g. , avoid incarceration , monetary penalty , etc . ) participate substance abuse treatment program 13 . History glaucoma 14 . Individuals report use MAOI within 14 day study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Cocaine</keyword>
	<keyword>Treatment</keyword>
</DOC>